News

Pfizer-developed Covid Pill Cuts Hospitalizations And Deaths By 89% Headline Second

Pfizer Inc. said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%, a result that has the....

Covaxin-vaccinated travelers allowed to enter the U.S from Nov.8 – Details Headline Second

Travelers who have received both doses of Bharat Biotech’s Covid-19 vaccine Covaxin will be allowed to enter the US from....

Merck’s COVID-19 pill gets UK authorization, first country to approve the ‘game-changing’ therapy Headline Second

Britain has granted a conditional authorization to Merck’s coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is....

WHO expert panel approves Bharat Biotech’s Covaxin for emergency use Headline Second

The Technical Advisory Group of WHO on Wednesday, November 3, recommended Emergency Use Listing status for Bharat Biotech’s Covaxin. “The....

India extends Covid restrictions until Nov.30 Headline Second

Govt. of India has extended Covid restrictions to prevent another wave for one more month. Therefore the restrictions will remain....

Room spray made in India kills two in the U.S: CDC Headline Second

An aromatherapy spray, manufactured in India and being sold in the US, has been found to contain a bacteria that....

Covaxin approval: WHO official says approval ‘takes longer sometimes’ Headline Second

The World Health Organisation (WHO) said on Friday the process of approval of Bharat Biotech’s Covaxin – Indigenous  vaccine of....

India achieves landmark 100 crore Covid vaccine administration Headline Second

India achieved 100 crore Covid-19 vaccine doses landmark on Thursday. India completed administering 1 billion doses of Covid-19 vaccines, as....

Third Dose Of Pfizer Vaccine 95.6% Effective: Study Headline Second

A third dose of the vaccine against COVID-19 developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to....

Bharat Biotech’s Covaxin Jab Recommended For Children In India Headline Stories

An expert panel has recommended Bharat Biotech’s Covaxin for vaccinating children between the ages of two and 18 against Covid-19.....